{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T13:35:22Z","timestamp":1775136922239,"version":"3.50.1"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Adv Skin Wound Care"],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>Skin autofluorescence (SAF) has been suggested as a novel and noninvasive technique for assessing tissue accumulation of advanced glycation end products in diabetes and related complications. The aim of this systematic review and meta-analysis was to evaluate the use of SAF in diabetic foot ulcers (DFUs).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA SOURCES<\/jats:title>\n            <jats:p>PubMed\/MEDLINE and other digital databases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>STUDY SELECTION<\/jats:title>\n            <jats:p>The authors included studies comparing the SAF levels in patients with DFU with a non-DFU group to determine its association with DFU risk.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA EXTRACTION<\/jats:title>\n            <jats:p>Collected data included the SAF method and its values in DFU and non-DFU groups, covariates used in adjustment along with the unadjusted and\/or multivariate adjusted odds ratios (ORs) for the association of SAF with DFU risk, and other study characteristics.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA SYNTHESIS<\/jats:title>\n            <jats:p>A total of six studies were included in this meta-analysis. Five studies that involved 611 participants were included to compare SAF methods. Compared with the non-DFU group, the DFU group showed a significantly increased level of SAF (standardized mean difference, 0.67; 95% confidence interval [CI], 0.32\u20131.01; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .001). The results of meta-analysis of ORs revealed that the increased SAF level was independently associated with increased DFU risk in both unadjusted (OR, 3.16; 95% CI, 2.18\u20134.57; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .001) and adjusted models (OR, 3.07; 95% CI, 1.95\u20134.81; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS<\/jats:title>\n            <jats:p>These findings suggest that SAF could be useful as a novel and noninvasive technology to help determine DFU risk. However, further studies establishing its diagnostic and prognostic utilities are needed.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/01.asw.0000792932.01773.d5","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T20:09:18Z","timestamp":1634760558000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Skin Autofluorescence as a Novel and Noninvasive Technology for Advanced Glycation End Products in Diabetic Foot Ulcers: A Systematic Review and Meta-analysis"],"prefix":"10.1097","volume":"34","author":[{"given":"Seshadri Reddy","family":"Varikasuvu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurabh","family":"Varshney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harish","family":"Sulekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20250615","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/07853890.2016.1231932","article-title":"Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis","volume":"49","year":"2017","journal-title":"Ann Med"},{"key":"bib2-20250615","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","article-title":"Global estimates of diabetes prevalence for 2013 and projections for 2035","volume":"103","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"bib3-20250615","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/iwj.12816","article-title":"Diabetic foot ulcer management in clinical practice in the UK: costs and outcomes","volume":"15","year":"2018","journal-title":"Int Wound J"},{"key":"bib4-20250615","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","year":"2008","journal-title":"N Engl J Med"},{"key":"bib5-20250615","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s10719-016-9683-1","article-title":"Skin fluorescence as a clinical tool for non-invasive assessment of advanced glycation and long-term complications of diabetes","volume":"33","year":"2016","journal-title":"Glycoconj J"},{"key":"bib6-20250615","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2337\/dc07-1755","article-title":"Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complications","volume":"31","year":"2008","journal-title":"Diabetes Care"},{"key":"bib7-20250615","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2337\/dc06-1391","article-title":"Skin autofluorescence is a strong predictor of cardiac mortality in diabetes","volume":"30","year":"2007","journal-title":"Diabetes Care"},{"key":"bib8-20250615","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.mvr.2015.07.008","article-title":"In diabetic Charcot neuroarthropathy impaired microvascular function is related to long lasting metabolic control and low grade inflammatory process","volume":"101","year":"2015","journal-title":"Microvasc Res"},{"key":"bib9-20250615","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1177\/1932296819853555","article-title":"Within- and between-body-site agreement of skin autofluorescence measurements in people with and without diabetes-related foot disease","volume":"13","year":"2019","journal-title":"J Diabetes Sci Technol"},{"key":"bib10-20250615","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1631\/jzus.B1100249","article-title":"Elevated skin autofluorescence is strongly associated with foot ulcers in patients with diabetes: a cross-sectional, observational study of Chinese subjects","volume":"13","year":"2012","journal-title":"J Zhejiang Univ Sci B"},{"key":"bib11-20250615","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00125-005-1828-x","article-title":"Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy","volume":"48","year":"2005","journal-title":"Diabetologia"},{"key":"bib12-20250615","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1089\/dia.2013.0009","article-title":"Advanced glycation end products assessed by skin autofluorescence: a new marker of diabetic foot ulceration","volume":"15","year":"2013","journal-title":"Diabetes Technol Ther"},{"key":"bib13-20250615","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.diabres.2007.07.007","article-title":"Skin autofluorescence in type 2 diabetes: beyond blood glucose","volume":"79","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"key":"bib14-20250615","first-page":"18","article-title":"An observational study of foot ulceration risk in diabetic patients evaluated with autofluorescence: 195 cases cross-sectional and one-year outcome","volume":"330","year":"2012","journal-title":"Int J Diabetes Dev Ctries"},{"key":"bib15-20250615","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/1534734614568375","article-title":"The association between skin autofluorescence and vascular complications in Chinese patients with diabetic foot ulcer: an observational study done in Shanghai","volume":"14","year":"2015","journal-title":"Int J Low Extrem Wounds"},{"key":"bib16-20250615","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.2337\/dc12-0200","article-title":"Long-term prognosis of diabetic foot patients and their limbs: amputation and death over the course of a decade","volume":"35","year":"2012","journal-title":"Diabetes Care"},{"key":"bib17-20250615","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2337\/dc13-2176","article-title":"Burden of diabetic foot ulcers for Medicare and private insurers","volume":"37","year":"2014","journal-title":"Diabetes Care"},{"key":"bib18-20250615","first-page":"1069","article-title":"Factors in human serum interfere with the measurement of advanced glycation end products","volume":"44","year":"1998","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"bib19-20250615","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/wrr.12391","article-title":"WHS guidelines update: diabetic foot ulcer treatment guidelines","volume":"24","year":"2016","journal-title":"Wound Repair Regen"},{"key":"bib20-20250615","first-page":"106","article-title":"Skin autofluorescence\u2014a non-invasive measurement for assessing cardiovascular risk and risk of diabetes","volume":"10","year":"2014","journal-title":"Eur Endocrinol"},{"key":"bib21-20250615","article-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","journal-title":"Ottawa Hospital Research Institute"},{"key":"bib22-20250615","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.diabres.2004.09.004","article-title":"Advanced glycation end products\u2014role in pathology of diabetic complications","volume":"67","year":"2005","journal-title":"Diabetes Res Clin Pract"},{"key":"bib23-20250615","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4093\/dmj.2017.0105","article-title":"The role of advanced glycation end products in diabetic vascular complications","volume":"42","year":"2018","journal-title":"Diabetes Metab J"},{"key":"bib24-20250615","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1002\/dmrr.861","article-title":"Advanced glycation end products and diabetic foot disease","volume":"24","year":"2008","journal-title":"Diabetes Metab Res Rev"},{"key":"bib25-20250615","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1524-475X.2009.00518.x","article-title":"Advanced glycoxidation products and impaired diabetic wound healing","volume":"17","year":"2009","journal-title":"Wound Repair Regen"},{"key":"bib26-20250615","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/1534734605280130","article-title":"A review of the mechanisms implicated in the pathogenesis of the diabetic foot","volume":"4","year":"2005","journal-title":"Int J Low Extrem Wounds"},{"key":"bib27-20250615","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1464-5491.2011.03448.x","article-title":"Skin autofluorescence is associated with severity of vascular complications in Japanese patients with type 2 diabetes","volume":"29","year":"2012","journal-title":"Diabet Med"},{"key":"bib28-20250615","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2482-8-5","article-title":"Enhanced susceptibility to infections in a diabetic wound healing model","volume":"8","year":"2008","journal-title":"BMC Surg"},{"key":"bib29-20250615","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00125-007-0840-8","article-title":"Serum procalcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot study","volume":"51","year":"2008","journal-title":"Diabetologia"}],"container-title":["Advances in Skin &amp; Wound Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.ASW.0000792932.01773.d5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T21:05:46Z","timestamp":1750021546000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/01.ASW.0000792932.01773.d5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/01.asw.0000792932.01773.d5","relation":{},"ISSN":["1538-8654","1527-7941"],"issn-type":[{"value":"1538-8654","type":"electronic"},{"value":"1527-7941","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]}}}